HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousSexual BehaviorRisk FactorsSeroepidemiologic StudiesCohort StudiesAntibodies, ViralAntibodies, BacterialPrevalenceChlamydophila pneumoniaeImmunoglobulin GChlamydophila InfectionsSerologic TestsEnzyme-Linked Immunosorbent AssayHIV SeronegativityProspective StudiesCross-Sectional StudiesHelicobacter pyloriHelicobacter InfectionsAge FactorsIncidenceAcquired Immunodeficiency SyndromeToxocariasisAntibodies, ProtozoanCase-Control StudiesUnited StatesHIV-1Cytomegalovirus InfectionsAIDS SerodiagnosisOdds RatioToxoplasmosisHepatitis CHerpesvirus 2, HumanRural PopulationFollow-Up StudiesRetrospective StudiesBlood DonorsToxocaraLogistic ModelsBrazilQuestionnairesDisabled PersonsPapillomavirus InfectionsCD4 Lymphocyte CountMultivariate AnalysisAnti-HIV AgentsNeosporaHerpes GenitalisSyphilisAge DistributionSex FactorsLongitudinal StudiesTime FactorsCytomegalovirusPregnancyHomosexuality, MaleImmunoglobulin ARisk-TakingInfant, NewbornHomosexualityToxoplasmaSexual PartnersSocioeconomic FactorsImmunoglobulin MHepatitis A Virus, HumanHepatitis BAntibodies, HelminthHuman papillomavirus 16Urban PopulationAIDS-Related Opportunistic Infections